Back to search
FDAFDA · Food and drugs·Recall number D-0029-2025

Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24

Published November 6, 2024 · Recall initiated: October 21, 2024

Summary

FDA records drug Class II recall D-0029-2025, published November 6, 2024 and initiated October 21, 2024. Recalling firm: BLI International, Inc.; Status: Terminated; Reported quantity: 4,901 cases/24 count each case; Lot: Lot # 24A27724, Exp 01/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: Stability failure for assay at 6 months test time-point.

What to do

Voluntary: Firm initiated · Letter

Get an email if CHLORPHENIRAMINE MALEATE 4MG has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CHLORPHENIRAMINE MALEATE 4MG
Manufacturer
BLI International, Inc.
Distributor
Product was shipped to two private label customers ( OH & MO) as a final packaged product.
UPC
0092617099706
Lot
Lot # 24A27724, Exp 01/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24 recalled?

Yes. FDA published recall D-0029-2025 on November 6, 2024. Reported hazard: Superpotent Drug: Stability failure for assay at 6 months test time-point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CHLORPHENIRAMINE MALEATE 4MG. UPC: 0092617099706.